FDA Inspection
American Red Cross Blood ServicesAmerican Red Cross Blood Services – FDA Inspection, May 7, 2026
Record Details
This FDA Inspection record concerns American Red Cross Blood Services, with an inspection on May 7, 2026, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 61c90725-3965-4388-bcc2-1f600c5b6223
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1316906
- Project area
- Blood and Blood Products
Other FDA inspections of American Red Cross Blood Services
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 7, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 15, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 7, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 28, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 19, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American Red Cross Blood Services
- FDA Inspection 1180256 - 2022-09-07
- FDA Inspection 1056215 - 2018-05-15
- FDA Inspection 965411 - 2016-04-07
- FDA Inspection 863671 - 2014-01-28
- FDA Inspection 772139 - 2012-03-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.